Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Alcohol-related Liver DiseaseLiver Diseases
Interventions
BEHAVIORAL

ENGAGE-ALD Application (APP)

"Participants randomized to this will complete the app at the time of enrollment.~If in-person, will complete the app on a research laptop or iPad. The ENGAGE-ALD app consists of two modules developed based on preliminary data: 1) a misconception correction module and 2) a treatment matching module designed to match patients to participant's preferred form of alcohol treatment based on preferences for 19 different dimensions of alcohol treatment. The intervention will consist of administering a single session of the ENGAGE-ALD app."

BEHAVIORAL

Treatment Facilitation bundle

Participants will complete a survey. The module includes motivational interviewing-informed content tailored to address and assist in overcoming barriers. After taking the survey, participants will receive a virtual coaching session (either via phone or online virtual platform). Sessions will focus on identifying participant goals with respect to alcohol use and liver health, providing education on risks of alcohol use to liver health and risks of relapse, reviewing participants individually identified barriers to alcohol treatment, exploring benefits of and these barriers to alcohol treatment, and performing collaborative goal-setting, among other topics.

BEHAVIORAL

Enhanced Usual Care

This group will receive standard hepatology care, and an educational pamphlet defining alcohol treatment resources available within Michigan Medicine and giving information on how participants can access these resources. This information will be given directly to participants that enroll in person or e-mailed to participants or sent via postal mail for those that enroll remotely.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Michigan

OTHER

NCT06269510 - Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients | Biotech Hunter | Biotech Hunter